Ching-feng Cheng

Title: Innovations of Ching-feng Cheng in Obesity Treatment

Introduction

Ching-feng Cheng is a notable inventor based in New Taipei, Taiwan. She has made significant contributions to the field of medical science, particularly in the treatment and prevention of obesity and related disorders. Her innovative work has the potential to impact many lives by addressing critical health issues.

Latest Patents

Ching-feng Cheng holds a patent for ATF3 induction compounds. This invention relates to compounds designed for treating and/or preventing obesity and obesity-related disorders. Specifically, the invention provides chromanone derivatives that serve as ATF3 inducers, which can be utilized in the treatment and prevention of conditions such as heart disease, hypertension, hyperlipidemia, and diabetes.

Career Highlights

Throughout her career, Cheng has been associated with prestigious institutions, including Taipei Medical University and the National Research Institute of Chinese Medicine, under the Ministry of Health and Welfare. Her work in these organizations has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Ching-feng Cheng has collaborated with esteemed colleagues, including Heng Lin and Ming-jaw Don. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in healthcare.

Conclusion

Ching-feng Cheng's contributions to the field of obesity treatment through her patented innovations highlight her role as a leading inventor in medical science. Her work not only addresses critical health issues but also paves the way for future advancements in the treatment of obesity-related disorders.